View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsThai Central Chemical 過去の業績過去 基準チェック /16Thai Central Chemicalの収益は年間平均-5.4%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間7.3% 6.6%割合で 増加しています。 Thai Central Chemicalの自己資本利益率は7.2%であり、純利益率は6%です。主要情報-5.40%収益成長率-5.40%EPS成長率Chemicals 業界の成長8.05%収益成長率6.59%株主資本利益率7.19%ネット・マージン6.00%前回の決算情報30 Jun 2023最近の業績更新Reported Earnings • Aug 16Second quarter 2023 earnings released: EPS: ฿0.47 (vs ฿0.72 in 2Q 2022)Second quarter 2023 results: EPS: ฿0.47 (down from ฿0.72 in 2Q 2022). Revenue: ฿3.57b (down 20% from 2Q 2022). Net income: ฿275.9m (down 35% from 2Q 2022). Profit margin: 7.7% (down from 9.5% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.Reported Earnings • May 18First quarter 2023 earnings released: ฿0.056 loss per share (vs ฿0.14 loss in 1Q 2022)First quarter 2023 results: ฿0.056 loss per share (improved from ฿0.14 loss in 1Q 2022). Revenue: ฿1.85b (up 16% from 1Q 2022). Net loss: ฿32.6m (loss narrowed 60% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.Reported Earnings • Nov 18Third quarter 2022 earnings released: EPS: ฿0.85 (vs ฿0.69 in 3Q 2021)Third quarter 2022 results: EPS: ฿0.85 (up from ฿0.69 in 3Q 2021). Revenue: ฿5.02b (up 34% from 3Q 2021). Net income: ฿498.3m (up 24% from 3Q 2021). Profit margin: 9.9% (in line with 3Q 2021). Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 10% per year.Reported Earnings • Aug 17Second quarter 2022 earnings released: EPS: ฿0.72 (vs ฿1.23 in 2Q 2021)Second quarter 2022 results: EPS: ฿0.72 (down from ฿1.23 in 2Q 2021). Revenue: ฿4.44b (flat on 2Q 2021). Net income: ฿422.7m (down 41% from 2Q 2021). Profit margin: 9.5% (down from 16% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 8% per year.Reported Earnings • May 18First quarter 2022 earnings released: ฿0.14 loss per share (vs ฿0.54 profit in 1Q 2021)First quarter 2022 results: ฿0.14 loss per share (down from ฿0.54 profit in 1Q 2021). Revenue: ฿1.60b (down 14% from 1Q 2021). Net loss: ฿80.7m (down 125% from profit in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Reported Earnings • Feb 27Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ฿2.70 (up from ฿2.52 in FY 2020). Revenue: ฿12.1b (up 28% from FY 2020). Net income: ฿1.58b (up 7.2% from FY 2020). Profit margin: 13% (down from 16% in FY 2020). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.すべての更新を表示Recent updatesReported Earnings • Aug 16Second quarter 2023 earnings released: EPS: ฿0.47 (vs ฿0.72 in 2Q 2022)Second quarter 2023 results: EPS: ฿0.47 (down from ฿0.72 in 2Q 2022). Revenue: ฿3.57b (down 20% from 2Q 2022). Net income: ฿275.9m (down 35% from 2Q 2022). Profit margin: 7.7% (down from 9.5% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.New Risk • Aug 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Thai stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 93% Paying a dividend despite having no free cash flows. Earnings have declined by 5.3% per year over the past 5 years. High level of non-cash earnings (43% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Profit margins are more than 30% lower than last year (6.7% net profit margin).Valuation Update With 7 Day Price Move • Aug 03Investor sentiment deteriorates as stock falls 32%After last week's 32% share price decline to ฿26.75, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 18x in the Chemicals industry in Thailand. Total returns to shareholders of 54% over the past three years.Reported Earnings • May 18First quarter 2023 earnings released: ฿0.056 loss per share (vs ฿0.14 loss in 1Q 2022)First quarter 2023 results: ฿0.056 loss per share (improved from ฿0.14 loss in 1Q 2022). Revenue: ฿1.85b (up 16% from 1Q 2022). Net loss: ฿32.6m (loss narrowed 60% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.Upcoming Dividend • Mar 03Upcoming dividend of ฿1.40 per share at 4.3% yieldEligible shareholders must have bought the stock before 10 March 2023. Payment date: 18 May 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.3%. Lower than top quartile of Thai dividend payers (5.7%). Higher than average of industry peers (2.8%).Valuation Update With 7 Day Price Move • Feb 08Investor sentiment improves as stock rises 31%After last week's 31% share price gain to ฿38.75, the stock trades at a trailing P/E ratio of 23.1x. Average trailing P/E is 18x in the Chemicals industry in Thailand. Total returns to shareholders of 123% over the past three years.Reported Earnings • Nov 18Third quarter 2022 earnings released: EPS: ฿0.85 (vs ฿0.69 in 3Q 2021)Third quarter 2022 results: EPS: ฿0.85 (up from ฿0.69 in 3Q 2021). Revenue: ฿5.02b (up 34% from 3Q 2021). Net income: ฿498.3m (up 24% from 3Q 2021). Profit margin: 9.9% (in line with 3Q 2021). Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 10% per year.Board Change • Nov 16Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Suvat Suebsantikul was the last independent director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.Reported Earnings • Aug 17Second quarter 2022 earnings released: EPS: ฿0.72 (vs ฿1.23 in 2Q 2021)Second quarter 2022 results: EPS: ฿0.72 (down from ฿1.23 in 2Q 2021). Revenue: ฿4.44b (flat on 2Q 2021). Net income: ฿422.7m (down 41% from 2Q 2021). Profit margin: 9.5% (down from 16% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 8% per year.Reported Earnings • May 18First quarter 2022 earnings released: ฿0.14 loss per share (vs ฿0.54 profit in 1Q 2021)First quarter 2022 results: ฿0.14 loss per share (down from ฿0.54 profit in 1Q 2021). Revenue: ฿1.60b (down 14% from 1Q 2021). Net loss: ฿80.7m (down 125% from profit in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Director Suvat Suebsantikul was the last independent director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.Upcoming Dividend • Mar 02Upcoming dividend of ฿1.70 per shareEligible shareholders must have bought the stock before 09 March 2022. Payment date: 21 April 2022. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of Thai dividend payers (5.1%). Higher than average of industry peers (3.9%).Reported Earnings • Feb 27Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ฿2.70 (up from ฿2.52 in FY 2020). Revenue: ฿12.1b (up 28% from FY 2020). Net income: ฿1.58b (up 7.2% from FY 2020). Profit margin: 13% (down from 16% in FY 2020). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS ฿0.69 (vs ฿1.21 in 3Q 2020)The company reported a poor third quarter result with weaker earnings and profit margins, although revenues were flat. Third quarter 2021 results: Revenue: ฿3.74b (flat on 3Q 2020). Net income: ฿401.8m (down 43% from 3Q 2020). Profit margin: 11% (down from 19% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS ฿1.23 (vs ฿0.97 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: ฿4.42b (up 37% from 2Q 2020). Net income: ฿719.4m (up 27% from 2Q 2020). Profit margin: 16% (down from 18% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • May 18First quarter 2021 earnings released: EPS ฿0.54 (vs ฿0.15 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ฿1.87b (up 60% from 1Q 2020). Net income: ฿316.5m (up 266% from 1Q 2020). Profit margin: 17% (up from 7.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 1% per year.Valuation Update With 7 Day Price Move • May 10Investor sentiment improved over the past weekAfter last week's 17% share price gain to ฿37.00, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 21x in the Chemicals industry in Thailand. Total returns to shareholders of 16% over the past three years.Executive Departure • Apr 08President, CEO & Director Yoshihiro Tamura has left the companyOn the 26th of March, Yoshihiro Tamura, was replaced as CEO by Takahiro Yamashita after 3.0 years in the role. We don't have any record of a personal shareholding under Yoshihiro's name. A total of 5 executives have left over the last 12 months. Under Yoshihiro's leadership, the company delivered a total shareholder return of -12%.Reported Earnings • Feb 28Full year 2020 earnings released: EPS ฿2.52 (vs ฿1.58 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ฿9.43b (up 7.0% from FY 2019). Net income: ฿1.47b (up 60% from FY 2019). Profit margin: 16% (up from 11% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 10% per year.Is New 90 Day High Low • Feb 20New 90-day high: ฿30.00The company is up 15% from its price of ฿26.00 on 20 November 2020. The Thai market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 20% over the same period.Valuation Update With 7 Day Price Move • Nov 26Market bids up stock over the past weekAfter last week's 17% share price gain to ฿29.75, the stock is trading at a trailing P/E ratio of 11.8x, up from the previous P/E ratio of 10.1x. This compares to an average P/E of 11x in the Chemicals industry in Thailand. Total return to shareholders over the past three years is a loss of 22%.Reported Earnings • Nov 18Third quarter 2020 earnings released: EPS ฿1.21The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ฿3.70b (up 24% from 3Q 2019). Net income: ฿707.1m (up 89% from 3Q 2019). Profit margin: 19% (up from 13% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Nov 17New 90-day high: ฿25.00The company is up 14% from its price of ฿22.00 on 19 August 2020. The Thai market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period.Is New 90 Day High Low • Sep 29New 90-day high: ฿23.90The company is up 20% from its price of ฿19.90 on 01 July 2020. The Thai market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 10.0% over the same period.収支内訳Thai Central Chemical の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史SET:TCCC 収益、費用、利益 ( )THB Millions日付収益収益G+A経費研究開発費30 Jun 2312,258735674031 Mar 2313,134882593031 Dec 2212,886834551030 Sep 2213,127981525030 Jun 2211,847885521031 Mar 2211,8231,181543031 Dec 2112,0871,579553030 Sep 2111,3691,549556030 Jun 2111,3341,854623031 Mar 2110,1381,702648031 Dec 209,4341,472670030 Sep 209,4931,476677030 Jun 208,7781,144679031 Mar 208,712944707031 Dec 198,815922704030 Sep 198,790897705030 Jun 199,176924729031 Mar 199,9261,234707031 Dec 1810,3221,331715030 Sep 1810,5161,391756030 Jun 1811,1091,700726031 Mar 1811,1951,776698031 Dec 1711,5401,932669030 Sep 1711,8192,307663030 Jun 1712,8062,637675031 Mar 1712,6872,515706031 Dec 1612,2822,306699030 Sep 1612,5691,903702030 Jun 1612,1921,434722031 Mar 1612,4711,372693031 Dec 1512,6011,367702030 Sep 1512,6331,392666030 Jun 1513,8891,608617031 Mar 1514,3031,690634031 Dec 1414,9181,925624030 Sep 1416,7092,058770030 Jun 1417,8262,154840031 Mar 1420,2292,338913031 Dec 1322,3662,2521,063030 Sep 1322,2872,2081,001030 Jun 1322,2201,748940031 Mar 1322,4541,520866031 Dec 1222,2541,4597590質の高い収益: TCCCは 高品質の収益 を持っています。利益率の向上: TCCCの現在の純利益率 (6%)は、昨年(7.5%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: TCCCの収益は過去 5 年間で年間5.4%減少しました。成長の加速: TCCCは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: TCCCは過去 1 年間で収益成長率がマイナス ( -16.9% ) となったため、 Chemicals業界平均 ( 21% ) と比較することが困難です。株主資本利益率高いROE: TCCCの 自己資本利益率 ( 7.2% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/11/11 14:38終値2023/08/24 00:00収益2023/06/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Thai Central Chemical Public Company Limited これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Aug 16Second quarter 2023 earnings released: EPS: ฿0.47 (vs ฿0.72 in 2Q 2022)Second quarter 2023 results: EPS: ฿0.47 (down from ฿0.72 in 2Q 2022). Revenue: ฿3.57b (down 20% from 2Q 2022). Net income: ฿275.9m (down 35% from 2Q 2022). Profit margin: 7.7% (down from 9.5% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
Reported Earnings • May 18First quarter 2023 earnings released: ฿0.056 loss per share (vs ฿0.14 loss in 1Q 2022)First quarter 2023 results: ฿0.056 loss per share (improved from ฿0.14 loss in 1Q 2022). Revenue: ฿1.85b (up 16% from 1Q 2022). Net loss: ฿32.6m (loss narrowed 60% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 18Third quarter 2022 earnings released: EPS: ฿0.85 (vs ฿0.69 in 3Q 2021)Third quarter 2022 results: EPS: ฿0.85 (up from ฿0.69 in 3Q 2021). Revenue: ฿5.02b (up 34% from 3Q 2021). Net income: ฿498.3m (up 24% from 3Q 2021). Profit margin: 9.9% (in line with 3Q 2021). Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 10% per year.
Reported Earnings • Aug 17Second quarter 2022 earnings released: EPS: ฿0.72 (vs ฿1.23 in 2Q 2021)Second quarter 2022 results: EPS: ฿0.72 (down from ฿1.23 in 2Q 2021). Revenue: ฿4.44b (flat on 2Q 2021). Net income: ฿422.7m (down 41% from 2Q 2021). Profit margin: 9.5% (down from 16% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 8% per year.
Reported Earnings • May 18First quarter 2022 earnings released: ฿0.14 loss per share (vs ฿0.54 profit in 1Q 2021)First quarter 2022 results: ฿0.14 loss per share (down from ฿0.54 profit in 1Q 2021). Revenue: ฿1.60b (down 14% from 1Q 2021). Net loss: ฿80.7m (down 125% from profit in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Feb 27Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ฿2.70 (up from ฿2.52 in FY 2020). Revenue: ฿12.1b (up 28% from FY 2020). Net income: ฿1.58b (up 7.2% from FY 2020). Profit margin: 13% (down from 16% in FY 2020). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 16Second quarter 2023 earnings released: EPS: ฿0.47 (vs ฿0.72 in 2Q 2022)Second quarter 2023 results: EPS: ฿0.47 (down from ฿0.72 in 2Q 2022). Revenue: ฿3.57b (down 20% from 2Q 2022). Net income: ฿275.9m (down 35% from 2Q 2022). Profit margin: 7.7% (down from 9.5% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
New Risk • Aug 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Thai stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 93% Paying a dividend despite having no free cash flows. Earnings have declined by 5.3% per year over the past 5 years. High level of non-cash earnings (43% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Profit margins are more than 30% lower than last year (6.7% net profit margin).
Valuation Update With 7 Day Price Move • Aug 03Investor sentiment deteriorates as stock falls 32%After last week's 32% share price decline to ฿26.75, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 18x in the Chemicals industry in Thailand. Total returns to shareholders of 54% over the past three years.
Reported Earnings • May 18First quarter 2023 earnings released: ฿0.056 loss per share (vs ฿0.14 loss in 1Q 2022)First quarter 2023 results: ฿0.056 loss per share (improved from ฿0.14 loss in 1Q 2022). Revenue: ฿1.85b (up 16% from 1Q 2022). Net loss: ฿32.6m (loss narrowed 60% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.
Upcoming Dividend • Mar 03Upcoming dividend of ฿1.40 per share at 4.3% yieldEligible shareholders must have bought the stock before 10 March 2023. Payment date: 18 May 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.3%. Lower than top quartile of Thai dividend payers (5.7%). Higher than average of industry peers (2.8%).
Valuation Update With 7 Day Price Move • Feb 08Investor sentiment improves as stock rises 31%After last week's 31% share price gain to ฿38.75, the stock trades at a trailing P/E ratio of 23.1x. Average trailing P/E is 18x in the Chemicals industry in Thailand. Total returns to shareholders of 123% over the past three years.
Reported Earnings • Nov 18Third quarter 2022 earnings released: EPS: ฿0.85 (vs ฿0.69 in 3Q 2021)Third quarter 2022 results: EPS: ฿0.85 (up from ฿0.69 in 3Q 2021). Revenue: ฿5.02b (up 34% from 3Q 2021). Net income: ฿498.3m (up 24% from 3Q 2021). Profit margin: 9.9% (in line with 3Q 2021). Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 10% per year.
Board Change • Nov 16Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Suvat Suebsantikul was the last independent director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
Reported Earnings • Aug 17Second quarter 2022 earnings released: EPS: ฿0.72 (vs ฿1.23 in 2Q 2021)Second quarter 2022 results: EPS: ฿0.72 (down from ฿1.23 in 2Q 2021). Revenue: ฿4.44b (flat on 2Q 2021). Net income: ฿422.7m (down 41% from 2Q 2021). Profit margin: 9.5% (down from 16% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 8% per year.
Reported Earnings • May 18First quarter 2022 earnings released: ฿0.14 loss per share (vs ฿0.54 profit in 1Q 2021)First quarter 2022 results: ฿0.14 loss per share (down from ฿0.54 profit in 1Q 2021). Revenue: ฿1.60b (down 14% from 1Q 2021). Net loss: ฿80.7m (down 125% from profit in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Director Suvat Suebsantikul was the last independent director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
Upcoming Dividend • Mar 02Upcoming dividend of ฿1.70 per shareEligible shareholders must have bought the stock before 09 March 2022. Payment date: 21 April 2022. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of Thai dividend payers (5.1%). Higher than average of industry peers (3.9%).
Reported Earnings • Feb 27Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ฿2.70 (up from ฿2.52 in FY 2020). Revenue: ฿12.1b (up 28% from FY 2020). Net income: ฿1.58b (up 7.2% from FY 2020). Profit margin: 13% (down from 16% in FY 2020). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS ฿0.69 (vs ฿1.21 in 3Q 2020)The company reported a poor third quarter result with weaker earnings and profit margins, although revenues were flat. Third quarter 2021 results: Revenue: ฿3.74b (flat on 3Q 2020). Net income: ฿401.8m (down 43% from 3Q 2020). Profit margin: 11% (down from 19% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS ฿1.23 (vs ฿0.97 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: ฿4.42b (up 37% from 2Q 2020). Net income: ฿719.4m (up 27% from 2Q 2020). Profit margin: 16% (down from 18% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • May 18First quarter 2021 earnings released: EPS ฿0.54 (vs ฿0.15 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ฿1.87b (up 60% from 1Q 2020). Net income: ฿316.5m (up 266% from 1Q 2020). Profit margin: 17% (up from 7.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 1% per year.
Valuation Update With 7 Day Price Move • May 10Investor sentiment improved over the past weekAfter last week's 17% share price gain to ฿37.00, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 21x in the Chemicals industry in Thailand. Total returns to shareholders of 16% over the past three years.
Executive Departure • Apr 08President, CEO & Director Yoshihiro Tamura has left the companyOn the 26th of March, Yoshihiro Tamura, was replaced as CEO by Takahiro Yamashita after 3.0 years in the role. We don't have any record of a personal shareholding under Yoshihiro's name. A total of 5 executives have left over the last 12 months. Under Yoshihiro's leadership, the company delivered a total shareholder return of -12%.
Reported Earnings • Feb 28Full year 2020 earnings released: EPS ฿2.52 (vs ฿1.58 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ฿9.43b (up 7.0% from FY 2019). Net income: ฿1.47b (up 60% from FY 2019). Profit margin: 16% (up from 11% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 10% per year.
Is New 90 Day High Low • Feb 20New 90-day high: ฿30.00The company is up 15% from its price of ฿26.00 on 20 November 2020. The Thai market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 20% over the same period.
Valuation Update With 7 Day Price Move • Nov 26Market bids up stock over the past weekAfter last week's 17% share price gain to ฿29.75, the stock is trading at a trailing P/E ratio of 11.8x, up from the previous P/E ratio of 10.1x. This compares to an average P/E of 11x in the Chemicals industry in Thailand. Total return to shareholders over the past three years is a loss of 22%.
Reported Earnings • Nov 18Third quarter 2020 earnings released: EPS ฿1.21The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ฿3.70b (up 24% from 3Q 2019). Net income: ฿707.1m (up 89% from 3Q 2019). Profit margin: 19% (up from 13% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Nov 17New 90-day high: ฿25.00The company is up 14% from its price of ฿22.00 on 19 August 2020. The Thai market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period.
Is New 90 Day High Low • Sep 29New 90-day high: ฿23.90The company is up 20% from its price of ฿19.90 on 01 July 2020. The Thai market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 10.0% over the same period.